Frequently Asked Questions
How does this process differ from my normal diabetic treatment prescribed by my current physician?Other treatments deal with the symptoms of diabetes, rather than addressing the core issues associated with Type 1 and Type 2 diabetes. Rather than attempting to control blood sugar, or blood sugar swings, we deal with the root cause of diabetes – which is that a patient’s body has an abnormal metabolism which doesn’t allow it to process carbohydrates (primarily sugar) for energy.
Our treatment process restores the production of metabolic liver enzymes by mimicking how a healthy pancreas rhythmically secretes insulin to the liver. This is an essential metabolic function deficient, or completely lacking, in a diabetic person. It is a common misconception that out-of-control blood sugar is the main causal factor of advanced diabetes complications, but in fact it is an improper metabolism (the inability to use carbohydrates for cellular energy) that is the primary cause.
By correcting a diabetic patient’s metabolism, the advanced diabetic complications are halted or reversed, and patients get sustainable relief.
Will this treat both Type 1 and Type 2 diabetic patients?Yes.
Is this process covered under private insurance? Medicare?The ability to obtain insurance reimbursement for our procedures was originally established through favorable outcomes in a series of reimbursement legal cases in the late 1990’s. The reimbursement has been validated by the insurance history experienced over the first year of operation at the prototype APS clinic in Newport Beach, CA. Through August 2012, over 1000 treatments have been administered and were successfully reimbursed by Medicare and the following PPO’s; Blue Cross, Blue Shield, Aetna, Cigna, Health Net, Tricare, and others.
Can this cure my diabetes completely?No, but this process does help slow, stop, and even reverse secondary complications that arise as a result of diabetes. Many patients have had life changing results – see their testimonials here
How long does the process take?You can read the full treatment process here, but a simple answer is that on treatment days you can expect to spend roughly 5-6 hours in the facility undergoing treatment.
- The first treatments are done on back-to-back days in the first week
- The treatment is done over 1-hour periods with a 45 minute to 1-hour rest period between each session
- There is generally three courses each day of treatment.
- Typically, the treatment is performed on a weekly or bi-weekly basis following the first week of two back-to-back daily sessions.
How long has this treatment been in practice?Our specially created Microdose infusion pump is FDA 510k and CE cleared for the treatment of diabetes. It has strong intellectual property protection with ten (10) patents. Safe and validated, our Microdose infusion pump has been proven effective in clinical research studies conducted over 19 years. These studies included more than 100,000 individual treatments with no significant adverse reactions.
How is this pump different than the CSII pumps most Type 1 diabetic patients use?Most common diabetic pumps, like the CSII pumps, push insulin to the body using a subcutaneous infusion. Why does that matter? In order to signal the liver properly, you cannot use a subcutaneous infusion, it must be done using our specialized pump to access the portal vein. Our system ultimately ‘tricks’ the liver into thinking the pancreas is signaling the body to receive sugars, hence the name ‘Artificial Pancreas Treatment‘. Our process re-opens a critical pathway for a healthier metabolism—tissues heal, and the serious complications from advanced diabetes are halted or reversed.
Although insulin is frequently given IV in the hospital by pumps, this is not the same as this treatment process Trina Health utilizes in Fort Worth – simply because it is not pulsing, nor is there monitoring and regulating dosing by the Artificial Pancreas System® Metabolic Cart. In essence, our treatment perfuses insulin intelligently – engaging a naturally effective, holistic recovery process for the advanced-stage diabetic.
How does the pump work?The treatment is an intravenous therapy, administered in a clinical setting, that utilizes a precise high-pressure pulsation algorithm to intelligently perfuse insulin into a diabetic patient– effectively mimicking the effect that a normal pancreas has on the liver. The therapy stimulates the liver to produce critical metabolic enzymes otherwise absent or dramatically reduced in both Type 1 and Type 2 diabetic patients.
Will I be able to eat whatever I want, within reason, when I start the treatment process?Add explanation here.
How long will it take before I start to see results?Add explanation here.
How does the actual process work?The therapy stimulates the liver to produce critical metabolic enzymes otherwise absent or dramatically reduced in both Type 1 and Type 2 diabetic patients. Rather than working to control blood sugar, the process treats an advanced diabetic patient’s metabolic disorder by restoring their ability to properly convert carbohydrates into cellular energy. Because the onset and progression of advanced diabetes complications are due primarily to a patient’s inability to use carbohydrates for cellular energy, our treatment re-opens a critical pathway for a healthier metabolism—tissues heal, and the serious complications from advanced diabetes are halted or reversed.
I have had diabetes for (5, 10, 15) years, will this process help me?Yes. Many long suffering diabetic patients have seen life-changing results from our treatment process. You can see their testimonials here.
I suffer with (neuropathy, nephropathy, retinopathy, cardiomyopathy, poor wound healing, hypertension, impending amputations, heart complications), will this process help me?Yes. The benefit of this treatment process is that it effectively mimics the way a healthy pancreas excretes insulin in pulses. It results in normalized carbohydrate and lipid metabolism. It stops the complications of diabetes, and the tissues heal themselves. It let’s our bodies respond to problems how they are supposed to!
Neuropathy and Nervous System Diseases: Patients can expect to reverse neuropathy to approximately 5 years prior to treatment. If they could feel their feet five years ago they should be able to feel their feet again. Gastroparesis is a form of neuropathy so many patients have seen relief here. Increased sexual feeling and function is also a benefit of increasing circulation
Amputations: Virtually all amputations which are not imminent can be avoided because almost all wounds begin to heal.
Blindness: Retinal laser therapy is typically not necessary for patient with diabetic neuropathy within 5 months of starting the treatment and overall eyesight improves dramatically.
Heart Disease:Patients with diabetic cardiomyopathy can expect to reverse their lost ejection fractions, living normal lives.Stroke & High Blood Pressure: Virtually all patients will reduce hypertension, a leading cause of stroke.
Kidney Disease: Patients with as little as 33% function should never progress to dialysis while using the Artificial Pancreas Treatment. Many patients with more than 50% of kidney function should experience kidney improvements.How does the actual process work?Patients visit the clinic an agreed upon number of times monthly; once the visit schedule is established patients will visit and receive treatment. The Microdose treatment pump will mimic normal body functions for you and over a period of time you will begin to stop, slow, and even reverse some of the worst complications that come as a result of diabetes.Are there any scientific reviews I can read on the process?
Contact Trina Health of North Texas
- 1307 8th Ave #608, Fort Worth, TX 76104
- (817) 984-4676
- (817) 984-4678
- Google Map Link
From the Blog
- 17 Nov 2013APS Effect on Diabetic Autonomic NeuropathyThis is a randomized, controlled clinical study evaluating the abnormal windows 10 key sale circadia...
- 17 Nov 2013APS Effect on Diabetic NephropathyThis is a multi-center, retrospective, longitudinal study, involving 31 patients with type 1 diabete...